{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:09:13Z","timestamp":1784005753942,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17919"],"award-info":[{"award-number":["20K17919"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K24023"],"award-info":[{"award-number":["19K24023"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H03018"],"award-info":[{"award-number":["23H03018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03041"],"award-info":[{"award-number":["21H03041"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11060-023-04530-0","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T17:01:56Z","timestamp":1703696516000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective"],"prefix":"10.1007","volume":"166","author":[{"given":"Yuki","family":"Shinya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Umekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuto","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nakatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"key":"4530_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515\u2013521. https:\/\/doi.org\/10.1038\/363515a0","journal-title":"Nature"},{"key":"4530_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 Tumor suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"4530_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26:93\u201397","journal-title":"Otol Neurotol"},{"key":"4530_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"4530_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/neuonc\/nov200","volume":"18","author":"JO Blakeley","year":"2016","unstructured":"Blakeley JO, Plotkin SR (2016) Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol 18:624\u2013638. https:\/\/doi.org\/10.1093\/neuonc\/nov200","journal-title":"Neuro Oncol"},{"key":"4530_CR6","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR (2009) Neurofibromatosis type 2. Lancet 373:1974\u20131986. https:\/\/doi.org\/10.1016\/S0140-6736(09)60259-2","journal-title":"Lancet"},{"key":"4530_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DG Evans","year":"2009","unstructured":"Evans DG (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16. https:\/\/doi.org\/10.1186\/1750-1172-4-16","journal-title":"Orphanet J Rare Dis"},{"key":"4530_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","volume":"35","author":"DG Evans","year":"1998","unstructured":"Evans DG, Trueman L, Wallace A, Collins S, Strachan T (1998) Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe Disease associated with truncating mutations. J Med Genet 35:450\u2013455. https:\/\/doi.org\/10.1136\/jmg.35.6.450","journal-title":"J Med Genet"},{"key":"4530_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/s0035-3787(07)74175-9","volume":"163","author":"L Demange","year":"2007","unstructured":"Demange L, De Moncuit C, Thomas G, Olschwang S (2007) [Phenotype-genotype study in 154 French NF2 mutation carriers]. Rev Neurol (Paris) 163:1031\u20131038. https:\/\/doi.org\/10.1016\/s0035-3787(07)74175-9","journal-title":"Rev Neurol (Paris)"},{"key":"4530_CR10","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","volume":"97","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO, Collaboration REI (2021) Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology 97:S91\u2013S98. https:\/\/doi.org\/10.1212\/WNL.0000000000012436","journal-title":"Neurology"},{"key":"4530_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","volume":"52","author":"A Hexter","year":"2015","unstructured":"Hexter A, Jones A, Joe H et al (2015) Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients. J Med Genet 52:699\u2013705. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103290","journal-title":"J Med Genet"},{"key":"4530_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jmg.2004.029504","volume":"42","author":"ME Baser","year":"2005","unstructured":"Baser ME, Kuramoto L, Woods R et al (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet 42:540\u2013546. https:\/\/doi.org\/10.1136\/jmg.2004.029504","journal-title":"J Med Genet"},{"key":"4530_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","volume":"7","author":"DH Gutmann","year":"1998","unstructured":"Gutmann DH, Geist RT, Xu H, Kim JS, Saporito-Irwin S (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet 7:335\u2013345. https:\/\/doi.org\/10.1093\/hmg\/7.3.335","journal-title":"Hum Mol Genet"},{"key":"4530_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P et al (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54:657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"key":"4530_CR15","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) Corrigendum to: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017. Neuro Oncol 2020;22 https:\/\/doi.org\/10.1093\/neuonc\/noaa269","DOI":"10.1093\/neuonc\/noaa269"},{"key":"4530_CR16","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1016\/j.wneu.2017.11.163","volume":"110","author":"AM Langlois","year":"2018","unstructured":"Langlois AM, Iorio-Morin C, Masson-Cote L, Mathieu D (2018) Gamma Knife Stereotactic Radiosurgery for non-vestibular cranial nerve Schwannomas. World Neurosurg 110:e1031\u2013e1039. https:\/\/doi.org\/10.1016\/j.wneu.2017.11.163","journal-title":"World Neurosurg"},{"key":"4530_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00006123-200203000-00002","volume":"50","author":"S Sarma","year":"2002","unstructured":"Sarma S, Sekhar LN, Schessel DA (2002) Non-vestibular schwannomas of the brain: a 7-year experience. Neurosurgery 50:437\u2013448 discussion 438\u2013439. https:\/\/doi.org\/10.1097\/00006123-200203000-00002","journal-title":"Neurosurgery"},{"key":"4530_CR18","doi-asserted-by":"publisher","unstructured":"Wilkinson EP, Hoa M, Slattery WH 3rd, Fayad JN, Friedman RA, Schwartz MS, Brackmann DE (2011) Evolution in the management of facial nerve schwannoma. Laryngoscope 121:2065\u20132074. https:\/\/doi.org\/10.1002\/lary.22141","DOI":"10.1002\/lary.22141"},{"key":"4530_CR19","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.3171\/2014.7.FOCUS14341","volume":"37","author":"SM Raza","year":"2014","unstructured":"Raza SM, Donaldson AM, Mehta A, Tsiouris AJ, Anand VK, Schwartz TH (2014) Surgical management of trigeminal schwannomas: defining the role for endoscopic endonasal approaches. Neurosurg Focus 37:E17. https:\/\/doi.org\/10.3171\/2014.7.FOCUS14341","journal-title":"Neurosurg Focus"},{"key":"4530_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3171\/2012.10.JNS12523","volume":"118","author":"T Hasegawa","year":"2013","unstructured":"Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T (2013) Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife Surgery. J Neurosurg 118:557\u2013565. https:\/\/doi.org\/10.3171\/2012.10.JNS12523","journal-title":"J Neurosurg"},{"key":"4530_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1227\/01.neu.0000073416.22608.b3","volume":"53","author":"Y Iwai","year":"2003","unstructured":"Iwai Y, Yamanaka K, Shiotani M, Uyama T (2003) Radiosurgery for acoustic neuromas: results of low-dose treatment. Neurosurgery 53:282\u2013287 discussion 287\u2013288. https:\/\/doi.org\/10.1227\/01.neu.0000073416.22608.b3","journal-title":"Neurosurgery"},{"key":"4530_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3171\/2015.4.JNS142415","volume":"124","author":"S Klijn","year":"2016","unstructured":"Klijn S, Verheul JB, Beute GN, Leenstra S, Mulder JJ, Kunst HP, Hanssens PE (2016) Gamma Knife radiosurgery for vestibular schwannomas: evaluation of Tumor control and its predictors in a large patient cohort in the Netherlands. J Neurosurg 124:1619\u20131626. https:\/\/doi.org\/10.3171\/2015.4.JNS142415","journal-title":"J Neurosurg"},{"key":"4530_CR23","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJM199811123392003","volume":"339","author":"D Kondziolka","year":"1998","unstructured":"Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426\u20131433. https:\/\/doi.org\/10.1056\/NEJM199811123392003","journal-title":"N Engl J Med"},{"key":"4530_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/sup.2005.102.s_supplement.0195","volume":"102","author":"LD Lunsford","year":"2005","unstructured":"Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D (2005) Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 102:195\u2013199","journal-title":"J Neurosurg"},{"key":"4530_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3171\/2014.8.GKS141503","volume":"121 Suppl","author":"S Sun","year":"2014","unstructured":"Sun S, Liu A (2014) Long-term follow-up studies of Gamma Knife Surgery for patients with neurofibromatosis type 2. J Neurosurg 121 Suppl:143\u2013149. https:\/\/doi.org\/10.3171\/2014.8.GKS141503","journal-title":"J Neurosurg"},{"key":"4530_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3171\/jns.1999.90.5.0815","volume":"90","author":"BR Subach","year":"1999","unstructured":"Subach BR, Kondziolka D, Lunsford LD, Bissonette DJ, Flickinger JC, Maitz AH (1999) Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis type 2. J Neurosurg 90:815\u2013822. https:\/\/doi.org\/10.3171\/jns.1999.90.5.0815","journal-title":"J Neurosurg"},{"key":"4530_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000156907","volume":"21","author":"J Rowe","year":"2008","unstructured":"Rowe J, Radatz M, Kemeny A (2008) Radiosurgery for type II neurofibromatosis. Prog Neurol Surg 21:176\u2013182. https:\/\/doi.org\/10.1159\/000156907","journal-title":"Prog Neurol Surg"},{"key":"4530_CR28","first-page":"339","volume":"46","author":"PH Roche","year":"2000","unstructured":"Roche PH, Regis J, Pellet W, Thomassin JM, Gregoire R, Dufour H, Peragut JC (2000) [Neurofibromatosis type 2. Preliminary results of gamma knife radiosurgery of vestibular schwannomas]. Neurochirurgie 46:339\u2013353 discussion 354","journal-title":"Neurochirurgie"},{"key":"4530_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cncr.24036","volume":"115","author":"JH Phi","year":"2009","unstructured":"Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW (2009) Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: Tumor control and hearing preservation. Cancer 115:390\u2013398. https:\/\/doi.org\/10.1002\/cncr.24036","journal-title":"Cancer"},{"key":"4530_CR30","doi-asserted-by":"publisher","unstructured":"Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ, Lunsford LD (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460\u2013468; discussion 468\u2013470 https:\/\/doi.org\/10.1227\/01.NEU.0000255340.26027.53","DOI":"10.1227\/01.NEU.0000255340.26027.53"},{"key":"4530_CR31","first-page":"29","volume":"9","author":"N Massager","year":"2013","unstructured":"Massager N, Delbrouck C, Masudi J, De Smedt F, Devriendt D (2013) Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas. B-ENT 9:29\u201336","journal-title":"B-ENT"},{"key":"4530_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1227\/NEU.0000000000000264","volume":"74","author":"GW Mallory","year":"2014","unstructured":"Mallory GW, Pollock BE, Foote RL, Carlson ML, Driscoll CL, Link MJ (2014) Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for Tumor control and functional outcomes. Neurosurgery 74:292\u2013300 discussion 300\u2009\u2013\u2009291. https:\/\/doi.org\/10.1227\/NEU.0000000000000264","journal-title":"Neurosurgery"},{"key":"4530_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0090-3019(00)00174-9","volume":"53","author":"Y Kida","year":"2000","unstructured":"Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383\u2013389 discussion 389\u2013390","journal-title":"Surg Neurol"},{"key":"4530_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/neuonc\/nor171","volume":"14","author":"C Hayhurst","year":"2012","unstructured":"Hayhurst C, Zadeh G (2012) Tumor pseudoprogression following radiosurgery for vestibular schwannoma. Neuro Oncol 14:87\u201392. https:\/\/doi.org\/10.1093\/neuonc\/nor171","journal-title":"Neuro Oncol"},{"key":"4530_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jmedgenet-2020-106973","volume":"58","author":"Y Teranishi","year":"2021","unstructured":"Teranishi Y, Miyawaki S, Hongo H, Dofuku S, Okano A, Takayanagi S, Ota T, Yoshimura J, Qu W, Mitsui J, Nakatomi H, Morishita S, Tsuji S, Saito N (2021) Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2. J Med Genet 58:701\u2013711. https:\/\/doi.org\/10.1136\/jmedgenet-2020-106973","journal-title":"J Med Genet"},{"key":"4530_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/342716","volume":"71","author":"ME Baser","year":"2002","unstructured":"Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71:715\u2013723. https:\/\/doi.org\/10.1086\/342716","journal-title":"Am J Hum Genet"},{"key":"4530_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3171\/2016.9.JNS161463","volume":"128","author":"IJ Kruyt","year":"2018","unstructured":"Kruyt IJ, Verheul JB, Hanssens PEJ, Kunst HPM (2018) Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis type 2: a matched cohort study with sporadic vestibular schwannomas. J Neurosurg 128:49\u201359. https:\/\/doi.org\/10.3171\/2016.9.JNS161463","journal-title":"J Neurosurg"},{"key":"4530_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11060-010-0181-1","volume":"98","author":"MS Sharma","year":"2010","unstructured":"Sharma MS, Singh R, Kale SS, Agrawal D, Sharma BS, Mahapatra AK (2010) Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2. J Neurooncol 98:265\u2013270. https:\/\/doi.org\/10.1007\/s11060-010-0181-1","journal-title":"J Neurooncol"},{"key":"4530_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3171\/2014.8.GKS141506","volume":"121 Suppl","author":"N Boari","year":"2014","unstructured":"Boari N, Bailo M, Gagliardi F et al (2014) Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg 121 Suppl:123\u2013142. https:\/\/doi.org\/10.3171\/2014.8.GKS141506","journal-title":"J Neurosurg"},{"key":"4530_CR40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/neuros\/nyx027","volume":"81","author":"G Bowden","year":"2017","unstructured":"Bowden G, Cavaleri J, Monaco E III, Niranjan A, Flickinger J, Lunsford LD (2017) Cystic vestibular Schwannomas Respond Best to Radiosurgery. Neurosurgery 81:490\u2013497. https:\/\/doi.org\/10.1093\/neuros\/nyx027","journal-title":"Neurosurgery"},{"key":"4530_CR41","first-page":"331","volume":"59","author":"MH Ruttledge","year":"1996","unstructured":"Ruttledge MH, Andermann AA, Phelan CM et al (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of Disease. Am J Hum Genet 59:331\u2013342","journal-title":"Am J Hum Genet"},{"key":"4530_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.0.CO;2-L","volume":"77","author":"L Kluwe","year":"1998","unstructured":"Kluwe L, MacCollin M, Tatagiba M, Thomas S, Hazim W, Haase W, Mautner VF (1998) Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. Am J Med Genet 77:228\u2013233","journal-title":"Am J Med Genet"},{"key":"4530_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA et al (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23:1113\u20131124. https:\/\/doi.org\/10.1093\/neuonc\/noaa284","journal-title":"Neuro Oncol"},{"key":"4530_CR44","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/annonc\/mdq566","volume":"21","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Nguyen R, Knecht R, Bokemeyer C (2010) Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation. Ann Oncol 21:2294\u20132295. https:\/\/doi.org\/10.1093\/annonc\/mdq566","journal-title":"Ann Oncol"},{"key":"4530_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/neuonc\/nop010","volume":"12","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Nguyen R, Kutta H et al (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 12:14\u201318. https:\/\/doi.org\/10.1093\/neuonc\/nop010","journal-title":"Neuro Oncol"},{"key":"4530_CR46","doi-asserted-by":"publisher","unstructured":"Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd (2012) Bevacizumab for Progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 33:1046\u20131052. https:\/\/doi.org\/10.1097\/MAO.0b013e31825e73f5","DOI":"10.1097\/MAO.0b013e31825e73f5"},{"key":"4530_CR47","doi-asserted-by":"publisher","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361:358\u2013367. https:\/\/doi.org\/10.1056\/NEJMoa0902579","DOI":"10.1056\/NEJMoa0902579"},{"key":"4530_CR48","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1212\/WNL.0000000000000997","volume":"83","author":"J Blakeley","year":"2014","unstructured":"Blakeley J, Schreck KC, Evans DG et al (2014) Clinical response to bevacizumab in schwannomatosis. Neurology 83:1986\u20131987. https:\/\/doi.org\/10.1212\/WNL.0000000000000997","journal-title":"Neurology"},{"key":"4530_CR49","doi-asserted-by":"publisher","unstructured":"Liu P, Yao Q, Li NA et al (2016) Low-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: a case report and literature review. Oncol Lett 11:2981\u20132986. https:\/\/doi.org\/10.3892\/ol.2016.4347","DOI":"10.3892\/ol.2016.4347"},{"key":"4530_CR50","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1200\/JCO.2011.38.2614","volume":"30","author":"V Subbiah","year":"2012","unstructured":"Subbiah V, Slopis J, Hong DS, Ketonen LM, Hamilton J, McCutcheon IE, Kurzrock R (2012) Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside. J Clin Oncol 30:e64\u201368. https:\/\/doi.org\/10.1200\/JCO.2011.38.2614","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04530-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T06:15:55Z","timestamp":1706595355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04530-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["4530"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04530-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of The University of Tokyo Hospital (IRB #2231 and G#10026).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}